Vermillion (Nasdaq: VRML) presents positive data of CA125 for the identification of malignant ovarian tumors at the 42nd Annual Meeting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE